China SXT Pharmaceuticals (SXTC) Leases (2023 - 2025)
China SXT Pharmaceuticals has reported Leases over the past 3 years, most recently at $176648.0 for Q1 2025.
- For Q1 2025, Leases fell 25.1% year-over-year to $176648.0; the TTM value through Mar 2025 reached $176648.0, down 25.1%, while the annual FY2025 figure was $176648.0, 25.1% down from the prior year.
- Leases for Q1 2025 was $176648.0 at China SXT Pharmaceuticals, down from $235848.0 in the prior quarter.
- Over five years, Leases peaked at $306050.0 in Q1 2023 and troughed at $176648.0 in Q1 2025.
- A 3-year average of $239515.3 and a median of $235848.0 in 2024 define the central range for Leases.
- Biggest five-year swings in Leases: dropped 22.94% in 2024 and later dropped 25.1% in 2025.
- Year by year, Leases stood at $306050.0 in 2023, then fell by 22.94% to $235848.0 in 2024, then dropped by 25.1% to $176648.0 in 2025.
- Business Quant data shows Leases for SXTC at $176648.0 in Q1 2025, $235848.0 in Q1 2024, and $306050.0 in Q1 2023.